Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

There is increasing evidence suggesting that some tumours originate from a stem cell population. Such observations appear to support the hypothesis that tumours can be generated and maintained by a small subset of undifferentiated cells able to self renew and differentiate into the bulk tumour population. Recently, cells with cancer stem cell-like properties have been identified within breast cancer tissues suggesting that a proportion of breast cancers may originate from such progenitors. Moreover, the intrinsic resistance of cancer stem cells (CSCs) to a range of chemotherapies suggests that their presence in breast cancer may also play a significant role in the development of an endocrine-resistant state. Future clarification of the role that CSCs play in such tumours, particularly in the context of therapeutic resistance, may lead to new treatment strategies for breast cancer where targeting of the CSCs specifically could lead to better and more sustained responses. © Springer Science+Business Media B.V. 2009.

Original publication

DOI

10.1007/978-1-4020-8526-0_6

Type

Chapter

Book title

Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets

Publication Date

01/01/2009

Pages

97 - 109